Stocks
Vanda Pharmaceuticals (VNDA) ROE US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| ROE, % | ? | 6.57% | 1.19% | 0.46% | -3.51% | -67.4% | -67.4% | |
| Changes by years, y/y, % | +1pp | -5pp | -1pp | -4pp | -64pp | |||
Vanda Pharmaceuticals. ROE, %
Vanda Pharmaceuticals. ROE, changes, pp
Vanda Pharmaceuticals (VNDA) ROE US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| ROE, % | ? | -3.51% | -8.65% | -13.8% | -18.1% | -67.4% | -67.4% | |
| Changes by years, y/y, % | -4pp | -8pp | -12pp | -15pp | -64pp | |||
| Changes by quarters, q/q, % | 0pp | -5pp | -5pp | -4pp | -49pp | |||
